Abstract:The classsical way and understanding for bone resoprtion and loss is mediated by the monocytes/macrophage‐derived osteoclasts. The present study reveals a different alternative pathway for bone resorption and loss, which is done via the immature dendritic cell‐derived osteoclasts with different phenotypic and factional activities: for example, through the step‐wise cytokine cross talks, in an animal model of arthritic bone loss, in vivo Background Dendritic cells (DCs), though borne heterogeneous, are the most potent antigen‐presenting cells, whose critical functions include triggering antigen‐specific naïve T‐cell responses and fine‐tuning the innate versus adaptive immunity at the osteo‐immune and/or mucosal mesenchyme interface. We previously reported that immature myeloid‐CD11c+DCs/mDCs may act like osteoclast (OC) precursors (OCp/mDDOCp) capable of developing into functional OCs via an alternative pathway of inflammation‐induced osteoclastogenesis; however, what are their contribution and signaling interactions with key osteotropic cytokines (i.e., interleukin‐17 [IL‐17] and transforming growth factor‐β [TGF‐β]) to bearing such inflammatory bone loss in vivo remain unclear to date. Methods Herein, we employed mature adult bone marrow‐reconstituted C57BL/6 TRAF6(−/−)‐null chimeras without the classical monocyte/macrophage (Mo/Mφ)‐derived OCs to address their potential contribution to OCp/mDDOCp‐mediated osteoclastogenesis in the chicken type‐II‐collagen (CC‐II)‐induced joint inflammation versus arthritic bone loss and parallel associations with the double‐positive CD11c+TRAP+TRAF6‐null(−/−) DC‐like OCs detected in vivo via the quantitative dual‐immunohistochemistry and digital histomorphometry for analyses. Results The resulting findings revealed the unrecognized novel insight that (i) immature myeloid‐CD11c+TRAF6(−/−) TRAP+DC‐like OCs were involved, co‐localized, and strongly associated with joint inflammation and bone loss, independent of the Mo/Mφ‐derived classical OCs, in CC‐II‐immunized TRAF6(−/−)‐null chimeras, and (ii) the osteotropic IL‐17 may engage distinct crosstalk with CD11c+mDCs/mDDOCp before developing the CD11c+TRAP+TRAF6(−/−)OCs via a TGF‐β‐dependent interaction toward inflammation‐induced arthritic bone loss in vivo. Conclusion These results confirm and substantiate the validity of TRAF6(−/−)‐null chimeras to address the significance of immature mCD11c+TRAP+DC‐like OCs/mDDOCp subset for an alternative pathway of arthritic bone loss in vivo. Such CD11c+mDCs/mDDOCp‐associated osteoclastogenesis through the step‐wise twist‐in‐turns osteo‐immune cross talks are thereby theme highlighted to depict a summative re‐visitation proposed.

The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity

Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca2+ /NFATc1 Axis

Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology

DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption

TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.

RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens

NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)

Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells

Osteoclast Multinucleation: Review of Current Literature

Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis

RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis

The molecular understanding of osteoclast differentiation

DNA damage-inducible transcript 3 restrains osteoclast differentiation and function

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption

Distinct cross talk of IL‐17 & TGF‐β with the immature CD11c+TRAF6(−/−)‐null myeloid dendritic cell‐derived osteoclast precursor (mDDOCp) may engage signaling toward an alternative pathway of osteoclastogenesis for arthritic bone loss in vivo

The role of calcium release activated calcium channels in osteoclast differentiation

High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.

The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption

STIM1 controls calcineurin/Akt/mTOR/NFATC2-mediated osteoclastogenesis induced by RANKL/M-CSF

Bona fide dendritic cells are pivotal precursors for osteoclasts

Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression